The oxygen concentrator maker previously said it expected to make over $16m in annual sales, with 2025 revenues ‘not less’ ...

U.S.-headquartered medical device maker Belluscura said it was withdrawing its forecast for 2025 on Tuesday due to the latest U.S. tariffs on China.

Private equity firm Keensight says it no longer aims to strike a deal for the British medtech due to the ‘current ...

It has been a rollercoaster week for global stock markets, amid trade war concerns only to whipsaw back when President Trump ...

UK firms are scrambling to respond to bombshell tariffs unleashed last week after Donald Trump's White House upended global ...

Belluscura, the AIM-listed portable oxygen therapy business, today withdrew financial guidance amid uncertainty over the ...

The week’s biggest loser was mini-microcap Nativo Resources, which dropped 46% and is currently valued at £322,000. The catalysts appear to have been the issue of shares and warrants to acquire the ...

For 2025, it guides for production between 85,000 and 95,000 ounces with AISC guidance of between USD800 and USD1,000 per ounce. Zephyr Energy PLC, up 13% at 3.6 pence, 12-month range 2.4p-5.75p. The ...

The pound was quoted at USD1.2756 early on Tuesday in London, lower compared to USD1.2931 at the equities close on Monday. The euro stood at USD1.0941, down against USD1.0994. Against the yen, the ...

Some people may not like the taste, and the price may be a bit high for ... such as small canisters or portable oxygen concentrators. If you plan on using a portable oxygen concentrator, battery ...